September 22, 2014 4:57 PM ET


Company Overview of VBI Vaccines Inc

Company Overview

VBI Vaccines Inc operates as a biopharmaceutical company in the United States. The company develops eVLP a prophylactic cytomegalovirus vaccine platform that enables for the design of enveloped ‘e’ virus-like particle vaccines that closely mimic the target virus. The company is also developing thermostable technology platform that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. The company was formerly known as Paulson Capital (Delaware) Corp and changed its name to VBI Vaccines Inc in July 2014. The company was founded in 1970 and is headquartered in Cambridge, Massachusetts.

222 Third Street

Suite 2241

Cambridge, MA 02142

United States

Founded in 1970



Key Executives for VBI Vaccines Inc

Chief Executive Officer
Age: 53
Total Annual Compensation: $350.0K
Chief Financial Officer
Age: 48
Total Annual Compensation: $198.0K
Senior Vice President of Research
Age: 43
Total Annual Compensation: $220.0K
Vice President of Formulation Development
Age: 51
Total Annual Compensation: $215.0K
Compensation as of Fiscal Year 2013.

VBI Vaccines Inc Key Developments

VBI Vaccines Inc(NasdaqCM:VBIV) added to NASDAQ Composite Index

VBI Vaccines Inc will be added to the NASDAQ Composite Index.

VBI Vaccines Inc Announces Executive Changes

VBI Vaccines Inc. completed its merger with VBI Acquisition Corp. Effective upon the closing of the merger on July 25, 2014, executive officers prior to the merger, Trent D. Davis, President, Kellie M. Davis, Secretary and Treasurer, Lorraine Maxfield, Senior Vice President, Corporate Finance and Murray G. Smith, Chief Financial Officer, each tendered his or her resignation from all executive management positions then held with the company. Following the resignations, the members of the Board that were elected in connection with the closing of the merger, appointed the following individuals as the executive officers: Jeff Baxter as President and Chief Executive Officer, David Anderson as Senior Vice President, Research, Egidio Nascimento as Chief Financial Officer, Marc Kirchmeier as Vice President, Formulation Development and T. Adam Buckley as Vice President, Operations and Project Management. Jeff Baxter, FCMA - President, Chief Executive Officer and Director. Mr. Baxter, joined VBI in September of 2009, and has served as Chief Executive Officer and a member of the Board of Directors since September 2009. David E. Anderson, Vice President of Research. David E. Anderson, is an immunologist with expertise in the areas of vaccine development, autoimmunity and tumor immunology. Egidio Nascimento, Chief Financial Officer. Mr. Nascimento, joined VBI Sub in 2005, and has served as Chief Financial Officer since December 2006, with experience in finance and accounting, having previously worked as Vice President of Finance at Genome Canada and as Chief Financial Officer of two start-up companies. Marc Kirchmeier, Vice President of Formulations. Dr. Kirchmeier, has been Vice President, Vaccine Formulation Development at VBI since April 2010. Adam Buckley, Vice President of Operations and Project Management. Mr. Buckley, helped establish VBI Sub in 2001, and has served as Vice President, Operations and Project Management since January 2002.

VBI Vaccines Inc Presents at BioContactQuebec 2012, Oct-03-2012

VBI Vaccines Inc Presents at BioContactQuebec 2012, Oct-03-2012 . Venue: Château Laurier, Quebec City, Quebec, Canada. Speakers: Egidio Nascimento, Chief Financial Officer.

Similar Private Companies By Industry

Company Name Region
GlycoMark, Inc. United States
Zumbro Discovery, Inc. United States
Alice Therapeutics, Inc. United States
ChemGenes Corporation United States
Superior Supplements, Inc United States

Recent Private Companies Transactions

Private Placement
July 25, 2014
May 9, 2014
Paulson Capital (Delaware) Corp.
Private Placement
May 8, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VBI Vaccines Inc, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at